Hepatology Communications

🚨GI/Hep Fellowships start next week‼️ @HepCommJournal has the 📑 you need to thrive 💫 #GIHepFellowshipBootcamp First up, you get a consult for a #LiverMass, ✅ out this review about benign liver masses❕ 📍Hemangiomas 📍FNH 📍Hepatic Adenomas 📍Cysts journals.lww.com/hepcomm/fullte…

Co-Editors @ebtapper and Carmen Chak-Lui Wong share exciting science from the April issue of @HepCommJournal including a consensus statement on portal hypertension, advances in #HCC screening and treatment, insights into #MASH #cirrhosis, and emerging immune targets in #liverdisease. Watch below and view the latest issue here: bit.ly/4sf5gBm youtube.com/watch?v=gNJhEd…

📑 #Ascites in patients with end-stage #renal disease: Challenges and SOLUTIONS from diagnosis to management‼️ #OpenAccess #LiverX journals.lww.com/hepcomm/fullte…

📑 Reduced short-term survival following #liver transplant in patients with ACLF: Reevaluating OPTN data❕ #OpenAccess journals.lww.com/hepcomm/fullte…

📑 Treatment of #AUD in alcohol-associated liver disease: A meta-analysis❕ ⬆️ 🍻 Abstinence ⬇️ Readmissions 🏥 and decompensations journals.lww.com/hepcomm/fullte…

📑 The impact of #sarcopenia 💪🏾 and #frailty on decompensation in compensated cirrhosis: A systematic review‼️ ⬆️ Prevalence of Sarcopenia But, most studies with 🚫 increased risk of first decompensation❕ journals.lww.com/hepcomm/fullte…

🔥HOT TOPIC 📘@HepCommJournal Recompensation is the resolution of ascites and/or hepatic encephalopathy. To date, data on the rate and predictors of recompensation for patients with #MASH #cirrhosis are lacking. This multicenter study from Spain shows that one in four patients can recompensate. #MASLD bit.ly/41q3hhg

📑 Unique bile acid profiles in the bile ducts of patients with primary sclerosing cholangitis❗️ #PSC #LiverX journals.lww.com/hepcomm/fullte…

📑 BTLA deficiency promotes HSC activation and protects against hepatic ischemia-reperfusion injury‼️ #OpenAccess #LiverX journals.lww.com/hepcomm/fullte…

📑 Circulating bacterial peptides and linked metabolomic signatures are indicative of early mortality in pediatric #cirrhosis❗️ #OpenAccess #LiverX journals.lww.com/hepcomm/fullte…

📝 Submit your Letter of Interest for @HepCommJournal Editor-in-Chief by Friday, April 24! Don't miss the opportunity to shape editorial priorities, guide peer review and publication standards, and influence the global dissemination of emerging science in #liverdisease. 🔗 bit.ly/4lb7kqF

Quoted this study on the wards today Top downloaded article this year btw journals.lww.com/hepcomm/fullte… @theliverdoc @HepCommJournal

Every month I record a little video on the papers coming out in @HepCommJournal and I get so pumped See for yourself journals.lww.com/hepcomm/Pages/… Reviews on FMT, HCC screening, and the GESA Portal htn consensus. Second-line AIH treatment. MASH recompensation. HRS mgmt...

A must read by THE P.P. Bloom The past, present, and future of 💩 transplant in liver disease journals.lww.com/hepcomm/fullte… @BloomPringle @HepCommJournal @MayoClinicGIHep

📅 One month left to apply! AASLD is seeking candidates to serve as Editor-in-Chief of @HepCommJournal, the open access journal advancing high-quality basic, translational, and clinical hepatology research. This five-year leadership term offers the opportunity to shape editorial priorities, guide peer review and publication standards, and influence the global dissemination of emerging science in liver disease. Submit your letters of interest by Friday, Apr. 24: bit.ly/4s7wI3t

🔥 HOT TOPIC 📘 @HepCommJournal Blood-based biomarker screening represents a transformative advance in liver cancer surveillance, and this #HCC Early Detection Strategy (HEDS) study tackles the crucial challenges of optimizing test thresholds and interpreting how changes over time affect early detection performance. Read the full study here: bit.ly/4bBmDFX

Co-Editors @ebtapper and Carmen Chak-Lui Wong share exciting science from the February issue of @HepCommJournal including studies on the reproductive hormones and #MASLD, increases in patient quality of life on #Resmetirom, the role of cGAS beyond viral DNA sensing, new #HCC research, and much more. #LiverTwitter Watch below and view the latest issue here: bit.ly/4sf5gBm youtube.com/watch?v=WYDtqX…

The rate, predictors, and outcomes of recompensation in MASH cirrhosis @HepCommJournal journals.lww.com/hepcomm/fullte…

📑 Prevalence and outcomes of steatotic liver disease subtypes in older adults❕ journals.lww.com/hepcomm/fullte…

📑 Electronic decision aids enhance management of primary care patients with steatotic liver disease‼️ ➡️ Automated, FIB-4–based guidance   ➡️ Guideline adherence ⬆️ from 30% to 46%    One click closer to improved #MASLD care❕ journals.lww.com/hepcomm/fullte…

📑 Plasma proteome correlations with liver stiffness in pediatric cholestasis implicate epithelial to mesenchymal transition‼️ journals.lww.com/hepcomm/fullte…